基本信息
views: 8
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Bachelor in Biochemistry at Federal University of Viçosa (UFV-MG) (2008). Master of Science (2010) and PhD (2014) at School of Medicine of Ribeirão Preto, University of São Paulo (FMRP/USP), area of concentration: Basic and Applied Immunology (CAPES 7). Postdoctoral Fellow at the Pharmaceutical Company MedImmune/AstraZeneca in Cambridge-UK (from March/2015 to December/2016) in a partnership with the Brazilian Program Science Without Borders (SWB) and at the Immunochemistry Laboratory (Butantan Institute - São Paulo-SP, Brazil) (from June/2017 to April/2019). Currently a Postdoc Researcher at Italian Institute of Technology (IIT) in Naples, Italy working with Synthetic Promoters to sense T cell exhaustion specific transcription factors and improve CAR-T cell therapies. Excellent planning and organisational skills, ability to develop and conduct individual and collaborative research objectives. Worked recently in the field of Immuno-Oncology, using CRISPR/Cas9 system as an approach to introduce genetic modifications in cell lines. Has expertise in techniques such as human and mouse cell lines culturing, qPCR and flow cytometry. Has extensive experience also in cell and molecular biology, Immunoparasitology, Inflammation of the intestinal mucosa and Immunoregulation working with in vivo models, ELISA, immunohistochemistry, immunofluorescence, histology, molecular cloning and western blotting.
Research Interests
Papers共 20 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
VACCINESno. 4 (2020): 732
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn